MARKET

REVB

REVB

Revelation Biosciences
NASDAQ
1.030
-0.010
-0.96%
After Hours: 1.030 0 0.00% 18:06 06/30 EDT
OPEN
1.040
PREV CLOSE
1.040
HIGH
1.071
LOW
1.030
VOLUME
14.60K
TURNOVER
--
52 WEEK HIGH
12.88
52 WEEK LOW
0.8750
MARKET CAP
4.03M
P/E (TTM)
-0.0261
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at REVB last week (0622-0626)?
Weekly Report · 1d ago
Revelation Biosciences Updates Executive Contracts, Shareholder Actions
TipRanks · 6d ago
Revelation Biosciences shareholders approved board authority for reverse stock split range up to 1-for-250
PUBT · 6d ago
Weekly Report: what happened at REVB last week (0615-0619)?
Weekly Report · 06/22 10:25
Weekly Report: what happened at REVB last week (0608-0612)?
Weekly Report · 06/15 10:26
Weekly Report: what happened at REVB last week (0601-0605)?
Weekly Report · 06/08 10:22
Revelation Biosciences adds two new members to AKI Advisory Board
TipRanks · 06/01 13:56
Weekly Report: what happened at REVB last week (0525-0529)?
Weekly Report · 06/01 10:26
More
About REVB
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. The Company's product candidates are based on the Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD). The Company has multiple ongoing programs to evaluate Gemini, including GEM-AKI as a prevention of acute kidney injury (AKI), GEM-CKD as a treatment for chronic kidney disease (CKD), and GEM-PSI as a prevention of post-surgical infection (PSI). The Gemini-AKI program is being developed as a potential therapy for the prevention of AKI due to external stress or insult, such as surgical procedure and chemotherapy toxicity. GEM-PSI is being developed as a potential therapy for the prevention or treatment of healthcare-associated bacterial infections, including post-surgical infection, post-burn infection, urinary tract infection, sepsis, and antibiotic-resistant infection.

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVB stock methods without spending real money on the virtual paper trading platform.